Related references
Note: Only part of the references are listed.FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in
Song-Yang Zhang et al.
GUT (2021)
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model
Sang Youb Han et al.
ACTA DIABETOLOGICA (2021)
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
Marica Cariello et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Bile acids and their receptors in metabolic disorders
Stefano Fiorucci et al.
PROGRESS IN LIPID RESEARCH (2021)
FXR in liver physiology: Multiple faces to regulate liver metabolism
Katrin Panzitt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Farnesoid X receptor (FXR): Structures and ligands
Longying Jiang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis
Qing Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
Yixuan Qiu et al.
ANNALS OF MEDICINE (2021)
Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy
Sujing Qiang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Farnesoid X Receptor-Mediated Cytoplasmic Translocation of CRTC2 Disrupts CREB-BDNF Signaling in Hippocampal CA1 and Leads to the Development of Depression-Like Behaviors in Mice
Wenfeng Hu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK/PGC-1α pathway in skeletal muscle
Ai Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes
Saki Shinohara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Speci fi c DNA Motifs
Jose Miguel Ramos Pittol et al.
GASTROENTEROLOGY (2020)
Bile Acid Supplementation Improves Murine Pancreatitis in Association With the Gut Microbiota
You-Dong Wan et al.
FRONTIERS IN PHYSIOLOGY (2020)
Fxr-alpha Skips Alternatively in Liver Metabolism
Sayeepriyadarshini Anakk et al.
GASTROENTEROLOGY (2020)
Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis
Sangwon Byun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer's Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
Firas H. Bazzari et al.
MOLECULES (2019)
FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangements[S]
Tim van Zutphen et al.
JOURNAL OF LIPID RESEARCH (2019)
FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic β-Cells
Xiangchen Kong et al.
JOURNAL OF DIABETES RESEARCH (2019)
Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
Xiangchen Kong et al.
MOLECULAR METABOLISM (2019)
Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell
Pengzhou Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1
Lei Liu et al.
LIVER INTERNATIONAL (2019)
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Xiaoxin X. Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Farnesoid X receptor: A homeostat for hepatic nutrient metabolism
Vittoria Massafra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction
Yunlong Xia et al.
CARDIOVASCULAR RESEARCH (2018)
Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1
Xijun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Hippocampal FXR plays a role in the pathogenesis of depression: A preliminary study based on lentiviral gene modulation
Wei-Guan Chen et al.
PSYCHIATRY RESEARCH (2018)
Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice
Yi Gao et al.
EXPERIMENTAL CELL RESEARCH (2018)
An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
Cen Xie et al.
DIABETES (2017)
Small Heterodimer Partner Deletion Prevents Hepatic Steatosis and When Combined With Farnesoid X Receptor Loss Protects Against Type 2 Diabetes in Mice
Oludemilade Akinrotimi et al.
HEPATOLOGY (2017)
RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism
Elizabeth J. Tarling et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Activation of FXR pathway does not alter glial cell function
Stefanie Albrecht et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Berengere Benoit et al.
NATURE MEDICINE (2017)
The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis
Xiaodong Zhou et al.
CELL DEATH DISCOVERY (2017)
Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α
Shuai Wang et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets
Leonardo A. Moraes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Bile acid receptor agonists. INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice
Monique C. de Oliveira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Identification of functional farnesoid X receptors in brain neurons
Chao Huang et al.
FEBS LETTERS (2016)
Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
Yang Xu et al.
HEPATOLOGY (2016)
Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression
Qingli Liu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
MAFG Is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism
Thomas Q. de Aguiar Vallim et al.
CELL METABOLISM (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance
Mohamed Sham Shihabudeen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
Mohamed-Sami Trabelsi et al.
NATURE COMMUNICATIONS (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
Jorge C. Correia et al.
MOLECULAR METABOLISM (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Hepatic Carboxylesterase 1 Is Essential for Both Normal and Farnesoid X Receptor-Controlled Lipid Homeostasis
Jiesi Xu et al.
HEPATOLOGY (2014)
FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway
Dongju Jung et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
Xiaoyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells
Xiao-Min Xin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li et al.
PHARMACOLOGICAL REVIEWS (2014)
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
Javier Vaquero et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
Jun Pu et al.
EUROPEAN HEART JOURNAL (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma
Yuan Chen et al.
HEPATOLOGY (2013)
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
David van der Poorten et al.
HEPATOLOGY (2013)
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Elena Maneschi et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor
Xiulong Song et al.
JOURNAL OF LIPID RESEARCH (2013)
Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
Sandrine Caron et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice
Yanjun Jiang et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2013)
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity
A. Mencarelli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells
Zhaosha Li et al.
PHYSIOLOGICAL GENOMICS (2013)
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Yongjie Ma et al.
PHARMACEUTICAL RESEARCH (2013)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li et al.
NATURE COMMUNICATIONS (2013)
Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
Martina Duefer et al.
DIABETES (2012)
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Bo Kong et al.
HEPATOLOGY (2012)
FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice
Menno Hoekstra et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Fibroblast Growth Factor 19 Treatment Ameliorates Disruption of Hepatic Lipid Metabolism in Farnesoid X Receptor (Fxr)-Null Mice
Masaaki Miyata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Matthew J. Potthoff et al.
CELL METABOLISM (2011)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
Mitsuhiro Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR
Matthew D. Krasowski et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Serkan Kir et al.
SCIENCE (2011)
Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitro
Deanna L. Howarth et al.
AQUATIC TOXICOLOGY (2010)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
Iuliana Ristea Popescu et al.
FEBS LETTERS (2010)
The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
Mouaadh Abdelkarim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bile salts of vertebrates: structural variation and possible evolutionary significance
Alan F. Hofmann et al.
JOURNAL OF LIPID RESEARCH (2010)
Diversity of Bile Salts in Fish and Amphibians: Evolution of a Complex Biochemical Pathway
Lee R. Hagey et al.
PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY (2010)
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Sushant Bhatnagar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice
Helen B. Hartman et al.
JOURNAL OF LIPID RESEARCH (2009)
The farnesoid X receptor regulates transcription of 3β-hydroxysteroid dehydrogenase type 2 in human adrenal cells
Yewei Xing et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray
Hiroyuki Higashiyama et al.
ACTA HISTOCHEMICA (2008)
Bile acids: Chemistry, pathochemistry, biology, pathobiology, and therapeutics
A. F. Hofmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTπ, at the blood-brain barrier
Bjoern Bauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Evolution of the bile salt nuclear receptor FXR in vertebrates
Erica J. Reschly et al.
JOURNAL OF LIPID RESEARCH (2008)
FXR signaling in metabolic disease
Yanqiao Zhang et al.
FEBS LETTERS (2008)
Analysis of nuclear receptor pseudogenes in vertebrates: How the silent tell their stories
Zhengdong D. Zhang et al.
MOLECULAR BIOLOGY AND EVOLUTION (2008)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue
Sander M. Houten et al.
MOLECULAR ENDOCRINOLOGY (2007)
Effects of FXR in foam-cell formation and atherosclerosis development
Grace L. Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice
Yanqiao Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2006)
FXR, a multipurpose nuclear receptor
Florence Y. Lee et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
S Bilz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes
JF Landrier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells
FT He et al.
CIRCULATION RESEARCH (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine
H Lee et al.
JOURNAL OF LIPID RESEARCH (2006)
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
EA Hanniman et al.
JOURNAL OF LIPID RESEARCH (2005)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: A potential role for a negative farnesoid X receptor response element
Y Lu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Expression and activation of the farnesoid X receptor in the vasculature
D Bishop-Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Regulation of CYP3A4 by the bile acid receptor FXR:: evidence for functional binding sites in the CYP3A4 gene
C Gnerre et al.
PHARMACOGENETICS (2004)
Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4
H Hirokane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes
L Fu et al.
ENDOCRINOLOGY (2004)
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
K Yamagata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity
O Barbier et al.
GASTROENTEROLOGY (2003)
Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter
F Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structural basis for bile acid binding and activation of the nuclear receptor FXR
LZ Mi et al.
MOLECULAR CELL (2003)
Hepatocyte nuclear factor 1α:: A key mediator of the effect of bile acids on gene expression
D Jung et al.
HEPATOLOGY (2003)
Bile acids induce the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor
IP Torra et al.
MOLECULAR ENDOCRINOLOGY (2003)
Identification of farnesoid X receptor β as a novel mammalian nuclear receptor sensing lanosterol
K Otte et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation
YQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
FOR, a novel orphan nuclear receptor related to farnesoid X receptor
YW Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
RM Huber et al.
GENE (2002)
Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor
HR Kast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor
CS Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transcriptional regulation of the human sterol 12α-hydroxylase gene (CYP8B1) -: Roles of hepatocyte nuclear factor 4α in mediating bile acid repression
M Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
M Ananthanarayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp
LA Denson et al.
GASTROENTEROLOGY (2001)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Share Paper
